C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
02/1993
02/24/1993	EP0237522B1 Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them
02/23/1993	CA1313873C Glycoluril derivatives and their use as stabilizers for polymers
02/22/1993	CA2076431A1 Condensed pyrimidine derivative
02/18/1993	WO1993003041A1 Geneserine derivatives as cholinesterase inhibitors
02/18/1993	WO1993003034A1 Quinazoline derivatives as acetylcholinesterase inhibitors
02/18/1993	CA2115250A1 Geneserine derivatives as cholinesterase inhibitors
02/18/1993	CA2113115A1 Quinazoline derivatives as acetylcholinesterase inhibitors
02/10/1993	EP0526708A1 Sulfonamide, preparation and use thereof as medicine and intermediate
02/10/1993	EP0526543A1 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
02/10/1993	EP0526529A1 An improved process for the preparation of substituted indolone derivatives.
02/10/1993	CN1068820A (s)(+)-2-ethoxy-4-(n-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl)-benzoic acid, pharmaceutical compositions containing compound and processes for preparation thereof
02/10/1993	CN1068819A Selective aromatase inhibiting 4(5)-imidazoles
02/09/1993	US5185343 Nortropyl-1-alkanol derivatives as antiischemic agents
02/09/1993	US5185025 Substituted pyrazoles and their use as herbicides
02/03/1993	WO1993003013A1 Indoline derivatives having an amide function, their preparation, and pharmaceutical compositions containing them
02/03/1993	EP0526348A1 Indoline derivatives carrying an amide function, their preparation and pharmaceutical compositions containing them
02/03/1993	EP0525057A1 Antimicrobial quinolonyl lactams
02/03/1993	EP0308476B1 Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation
02/03/1993	CN1068568A Benzofuran derivatives and pharmaceutical composition
01/1993
01/20/1993	CA2072897A1 Manganese (ii) complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
01/13/1993	CN1067892A Process for preparing pyrrolo ( 2,3-b) pyridine derivatives
01/12/1993	US5179120 Porphycene compounds for photodynamic therapy
01/12/1993	CA1312603C Process for the preparation of quinoline-carboxylic acid derivatives
01/07/1993	WO1993000344A1 Carbapenem derivative
01/07/1993	WO1993000337A1 (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
01/07/1993	WO1993000087A1 Porphycene compounds for photodynamic therapy
01/07/1993	WO1993000086A1 Use of tetrahydrocarbazone derivatives as 5ht1 receptor agonists
01/07/1993	WO1992015561A3 Process for preparing trans-piperidine-2,5-dicarboxylates
01/07/1993	CA2111323A1 Porphycene compounds for photodynamic therapy
01/06/1993	CN1067654A Processes for diastereoselective synthesis of nucleosides
01/05/1993	US5177217 Process for the manufacture of (S)-3-amino-1-substituted-pyrrolidines
12/1992
12/30/1992	CN1067428A 奎宁环衍生物 Quinuclidine derivatives
12/29/1992	CA1312077C Process for preparing 1,5-benzothiazepine derivatives
12/23/1992	WO1992022537A1 New selective aromatase inhibiting 4(5)-imidazoles
12/23/1992	EP0519547A2 Coccidiosis poultry vaccine
12/23/1992	EP0519307A2 Tetracyclic Imidazodiazepines
12/23/1992	CN1067245A Processes for diastereoselective synthesis of nucleosides
12/23/1992	CA2111469A1 New selective aromatase inhibiting 4(5)-imidazoles
12/19/1992	CA2071395A1 Coccidiosis poultry vaccine
12/18/1992	CA2069382A1 Imidazodiazepine
12/16/1992	CN1019492B Imidazodiazepine derivatives
12/09/1992	CN1066848A Isoxazolylimidazole derivatives, process for their production and their use in pharmaceutical agents
12/09/1992	CN1019387B Process for prepn. of propanol derivatives
12/02/1992	EP0515940A1 New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions
12/02/1992	CN1066658A Asymmetric synthesis of 3-substituted furanoside compounds
12/01/1992	WO1992021677A1 bibNUCLIDINE DERIVATIVES
12/01/1992	CA2069860A1 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
11/1992
11/26/1992	WO1992020696A1 Processes for the diastereoselective synthesis of nucleosides
11/26/1992	WO1992020669A1 Processes for the diastereoselective synthesis of nucleosides
11/25/1992	EP0515157A1 Processes for the diastereoselective synthesis of nucleosides
11/25/1992	EP0515156A1 Processes for the diastereo-selective synthesis of nucleosides
11/19/1992	EP0513200A1 Method and compositions for the synthesis of bch-189 and related compounds
11/17/1992	US5164494 Cephalosporin derivatives
11/17/1992	US5164400 Pyrroloquinoline compounds
11/11/1992	EP0512901A1 Aminated polycyclic compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them
11/11/1992	EP0409862B1 Topical preparations
11/11/1992	CA2068226A1 Asymmetric synthesis of 3-substituted furanoside compounds
11/10/1992	US5162319 Fungicides
11/02/1992	CA2067723A1 Antheilmintic milbemycin analogs of novel microorganisms
10/1992
10/29/1992	WO1992014743A3 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/28/1992	CN1065661A Heterocyclic compounds
10/27/1992	US5158773 Retinoid esters
10/27/1992	CA1309406C Cinnoline compounds
10/21/1992	EP0509974A1 Pyrrolo[2,3-b]pyridines having therapeutic activity and a process for the preparation thereof
10/21/1992	EP0509401A1 Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
10/20/1992	US5157034 Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
10/20/1992	CA2066059A1 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
10/15/1992	WO1992017475A1 Heterocyclic-cyclic amine derivatives
10/14/1992	EP0508792A1 Anti-tumor and anti-psoriatic agents
10/14/1992	CN1065267A Heterocyclic-cyclic amine derivatives
10/14/1992	CN1065264A Stereoselective preparation of substituted piperidines
10/13/1992	WO1992018500A1 Isoxazolyl imidazole derivatives, process for producing them and their use in medicaments
10/13/1992	US5155133 Antiarrhythmic compounds and pharmaceutical compositions and methods thereof
10/13/1992	CA2085242A1 Isoxazolylimidazole derivatives, process for their production and their use in pharmaceutical agents
10/12/1992	WO1992018507A1 Anti-tumor and anti-psoriatic agents
10/12/1992	CA2108146A1 Anti-tumor and anti-psoriatic agents
10/07/1992	EP0506759A1 Therapeutically active fluoro substituted benzimidazoles, processes for their preparation as well as their use
10/07/1992	CN1065065A Process for preparing 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/07/1992	CN1065063A 1-biphenylmethyl imidazole derivatives, their preparation and their therapeutic use
10/06/1992	US5153192 For controlling intraocular pressure
09/1992
09/30/1992	EP0505868A2 N-Acyl-alpha-aminoacids derivatives
09/30/1992	CN1064865A 4-((2-benzothiazolyl) methylamino)-alpha-((3,4-difluorophinoxy) methyl)-1-piperidineethanol
09/29/1992	US5151417 3-substituted vinyl cephalosporin derivatives
09/29/1992	CA1308106C Derivatives of 4-aminoquinoline and their use as medicaments
09/28/1992	WO1992017477A1 New active compounds
09/28/1992	CA2106880A1 Active compounds
09/27/1992	WO1992017449A1 Stereoselective preparation of substituted piperidines
09/27/1992	CA2061661A1 N-acyl-.alpha.-amino derivatives
09/23/1992	CN1064682A Heterocyclic compounds
09/17/1992	WO1992015582A1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO[4,5-c]QUINOLIN-4-AMINES
09/17/1992	WO1992015309A1 Antiviral nucleoside combination
09/17/1992	CA2439322A1 Therapeutic nucleosides
09/16/1992	EP0503785A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use
09/09/1992	CN1064271A 2,4-diaminoquinazolines derivatives for enhancing antitumor activity
09/09/1992	CN1064268A Process for preparing pharmaceutical composition containing salt of quinoline
09/03/1992	WO1992014743A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
09/03/1992	WO1992014731A1 4-[(2-BENZOTHIAZOLYL)METHYLAMINO]-α-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINEETHANOL
09/03/1992	WO1992014727A1 3-piperidinylmethylcarboxylate substituted indoles
09/03/1992	CA2105179A1 3-piperidinylmethylcarboxylate substituted indoles
09/02/1992	EP0501552A1 4-[(2-Benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol

1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 105